TipRanks
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
US Market
PLRX
Pliant Therapeutics
RESEARCH TOOLSreports
Want to see PLRX full AI Analyst Report?

Pliant Therapeutics (PLRX) Stock News & Sentiment

521 Followers
PLRX’s FORTIFY Trial: Early Oncology Bet With Upside for Immune-Oncology Investors
Premium
Company Announcements
PLRX’s FORTIFY Trial: Early Oncology Bet With Upside for Immune-Oncology Investors
4d ago
PLRX
PLRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PLRX Earnings this Week: How Will it Perform?
2M ago
PLRX
Pliant Therapeutics adds independent directors to strengthen R&D
Premium
Company Announcements
Pliant Therapeutics adds independent directors to strengthen R&D
3M ago
8K
PLRX
Pliant Therapeutics Shareholders Approve Directors and Executive Pay
Premium
Company Announcements
Pliant Therapeutics Shareholders Approve Directors and Executive Pay
4M ago
8K
PLRX
Analyst Reiterates Hold on Pliant Therapeutics, Keeps 12-Month Price Target Unchanged at $3 Amid Early-Stage Risk-Reward Balance
Premium
Ratings
Analyst Reiterates Hold on Pliant Therapeutics, Keeps 12-Month Price Target Unchanged at $3 Amid Early-Stage Risk-Reward Balance
5M ago
PLRX
PLRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PLRX Earnings this Week: How Will it Perform?
5M ago
PLRX
Pliant Therapeutics Announces Board Retirements and Option Repricing
Premium
Company Announcements
Pliant Therapeutics Announces Board Retirements and Option Repricing
6M ago
8K
PLRX
More PLRX News >

PLRX News on the Web

PLRX Earnings this Week: How Will it Perform?
TipRanks News
Neutral
Pliant Therapeutics adds independent directors to strengthen R&D
TipRanks News
Neutral
Pliant Therapeutics Shareholders Approve Directors and Executive Pay
TipRanks News
Neutral
Pliant Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
GuruFocus News
Neutral
Oppenheimer Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)
TipRanks News
Neutral
Analyst Reiterates Hold on Pliant Therapeutics, Keeps 12-Month Price Target Unchanged at $3 Amid Early-Stage Risk-Reward Balance
TipRanks News
Neutral
Piper Sandler Remains a Buy on Pliant Therapeutics (PLRX)
TipRanks News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ligand Pharma (LGND), Pliant Therapeutics (PLRX) and Oculis Holding (OCS)
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
PLRX
Sector Average
Media Buzz
This Week2 articles
Weekly Average0.25 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PLRX’s Media Buzz Sentiment?
2 articles about PLRX were published this week. In an average week, 0.25 articles are published.
    What is PLRX’s weekly average amount of articles?
    In an average week, 0.25 articles about PLRX are published.
      What is PLRX’s News Sentiment?
      50% of articles about PLRX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        REGNRegeneron
        QTTBQ32 Bio
        NVSNovartis
        RHHVFRoche Holding AG
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week